Return to the UMC Home Page

The University of Mississippi Brain Tumor Program has developed an extensive referral system for the diagnosis, management, rehabilitation and long-term care of patients with tumors of the brain, spinal cord, skull base, spine, peripheral nerves and nerve plexuses. The functions of the Adult Brain Tumor Program program are facilitated by the University’s state-of-the-art facilities and collaboration between the Departments of Neurology, Radiation Oncology, Neurosurgery, Medicine, Radiology, and Pathology.

The comprehensive management of tumors of the nervous system requires four stages: Diagnosis, Primary Treatment, Adjuvant Treatment, and Long Term Follow-up and Rehabilitation. Treatment usually consists of a combination of surgery, chemotherapy, and radiation.

Diagnostic Services

  • Newly diagnosed patients will be evaluated at the multidisciplinary Neuro-oncology Clinic at the UMC Thad Cochran Comprehensive Cancer Center.
  • Neuroradiological technology available at the UMC includes computed tomography (CT), magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), radionuclide SPECT scanning, PET scanning, and cerebral angiography.

  • Once a possible tumor has been identified, it is generally necessary to obtain tissue to confirm the diagnosis and identify the specific tumor type. The Department of Neurosurgery offers a complete array of diagnostic capabilities including open biopsy, frame-based and frameless (image-guided) stereotactic biopsy, and Interventional MRI-guided biopsy.

  • Following tumor biopsy, complete pathologic analysis including general histopathology, electron microscopy, immunopathology, hormone receptor analysis, cytogenetic studies, and flow cytometric DNA analysis are routinely available and performed by a dedicated neuropathologist. These studies allow a "tailored" approach to the management of some tumors.

  • Surgery and Radiosurgery

  • The Faculty members of the Department of Neurosurgery have extensive experience in the surgical treatment of tumors of the skull, skull base, spine, brain, spinal cord, peripheral nerves and brachial plexus. The Department of Neurosurgery employs state-of-the-art surgical instrumentation and technology in the management of brain and spinal tumors including frameless stereotaxy, intraoperative ultrasound, intraoperative cortical motor and language mapping and electrophysiological monitoring, the ultrasonic surgical aspirator, surgical laser, neuroendoscopy, and intraoperative angiography.
  • Intraoperative MRI: UMC was one of the first centers in the country to install the General Electric Signa SP Intraoperative MRI. This technology allows the surgeon to “see” the tumor during surgery, to ensure that the maximum amount of tumor is removed while preserving the normal brain tissue. This machine is available at only a handful of centers around the country.
  • Stereotactic radiosurgery is alternative to standard surgery in which the patient is given a one-time dose of focal radiation to the tumor. It is performed as an outpatient procedure in which the patient has a head-frame placed, an MRI scan is obtained, and then the radiation treatment is performed, which usually lasts less than one hour. We utilize linear-accelerator (LINAC)-based radiosurgery at the University of Mississippi Medical Center, as well as the Gamma Knife at the Robert R. Smith Gamma Knife Center.
  • In some cases, endovascular embolization of tumor vessels will be performed (through the Interventional Neuroradiology Program) to decrease the blood supply to the tumor, thus increasing the safety of surgical excision and decreasing the need for blood transfusion at the time of surgery.
  • The perioperative care of patients undergoing tumor surgery is facilitated by involvement of dedicated Neuro-anesthesiologists and Neuro-intensivists in the new UMC Neuroscience Intensive Care Unit.
  • Chemotherapy

    Because we concentrate on treating brain tumors, only the most up-to-date chemotherapy protocols are used and the specific needs of brain tumor patients receiving chemotherapy are addressed. Dr. Fredericks is currently the only dedicated neuro-oncologist practicing in the state of Mississippi.

    Radiation Therapy

  • The Department of Radiation Oncology, relocating to the UMC Comprehensive Cancer Center in the fall of 2004, will have state-of-the-art treatment planning and therapy equipment allowing for more precise delivery of radiation. In addition to traditional techniques, Intensity-Modulated Radiation Therapy (IMRT) combines multiple imaging sources (CT, MRI, PET, SPECT) to better define the target lesion. UMC will be one of the first 10 academic centers in the country to have this capacity. UMC will also be working with NASA to develop a 3-dimensional holographic system to further improve treatment planning.
  • New equipment will allow for stereotactic radiation to be delivered anywhere in the brain or spine. Like the Gamma Knife, which is limited to lesions in the head, this precise form of radiation is given as a one-time dose.
  • Long Term Follow-up and Rehabilitation

    Following treatment, an experienced team of physical, occupational, and speech therapists works in conjunction with the Brain Tumor team to develop a tailored plan of recovery for each patient. Nationally recognized adult and pediatric Rehabilitation Hospitals adjacent to the University Medical Center are available to persons requiring more intensive rehabilitative services. The UMC Brain Tumor Program works closely with the referring physician to coordinate the long-term follow-up and care of patients with tumors of the central and peripheral nervous systems.

    Research

  • Clinical Trials: UMC participates in several National Cancer Group Programs and Protocols investigating new treatments. UMC also participates in several multicenter trials of new chemotherapeutic agents.
  • In addition to the clinical research UMC participates in, tumor specimens are kept in the UMC Brain Tumor Laboratory’s tumor bank for use in molecular and genetic studies investigating the cause, diagnosis, and treatment of brain tumors.